Search for a Medicine

  • Medicines
 
 

Showing 61-80 of 113 matching medicines

Product listings were last updated on 08/10/2024
Trade Name Licence Number & Holder Documents
Tamsulosin Hydrochloride 400 micrograms Modified-release Capsules, hard
Modified-release capsule, hard


Generics List: Tamsulosin 400mcg Modified Release Capsules/Prolonged Release Capsules

Compare
PA0840/013/001
Authorised: 20/01/2006
Synthon BV
SPC PIL
Tamzeltos 400 micrograms prolonged-release tablets
Prolonged-release tablet


Generics List: Tamsulosin 400mcg Prolonged Release Tablets

Compare
PA1347/087/001
Authorised: 29/11/2019
KRKA, d.d., Novo mesto
SPC PIL
Tandemact
Tablet

Compare
EU/1/06/366/005-16
Authorised: 08/01/2007
CHEPLAPHARM Arzneimittel GmbH
SPC PIL IPAR
Tandemact
Tablet

Compare
EU/1/06/366/1-2
Authorised: 08/01/2007
CHEPLAPHARM Arzneimittel GmbH
SPC PIL IPAR
Tandemact
Tablet

Compare
EU/1/06/366/17-22
Authorised: 31/03/2008
CHEPLAPHARM Arzneimittel GmbH
SPC PIL IPAR
TANYZ 400 micrograms hard modified-release capsules
Modified-release capsule, hard


Generics List: Tamsulosin 400mcg Modified Release Capsules/Prolonged Release Capsules

Compare
PA1347/086/001
Authorised: 13/08/2019
KRKA, d.d., Novo mesto
SPC PIL
Tapentadol Liconsa 100 mg prolonged-release tablets
Prolonged-release tablet

Compare
PA1239/029/003
Authorised: 05/08/2022
Laboratorios LICONSA, S.A.
SPC PIL
Tapentadol Liconsa 150 mg prolonged-release tablets
Prolonged-release tablet

Compare
PA1239/029/004
Authorised: 05/08/2022
Laboratorios LICONSA, S.A.
SPC PIL
Tapentadol Liconsa 200 mg prolonged-release tablets
Prolonged-release tablet

Compare
PA1239/029/005
Authorised: 05/08/2022
Laboratorios LICONSA, S.A.
SPC PIL
Tapentadol Liconsa 25 mg prolonged-release tablets
Prolonged-release tablet

Compare
PA1239/029/001
Authorised: 05/08/2022
Laboratorios LICONSA, S.A.
SPC PIL
Tapentadol Liconsa 250 mg prolonged-release tablets
Prolonged-release tablet

Compare
PA1239/029/006
Authorised: 05/08/2022
Laboratorios LICONSA, S.A.
SPC PIL
Tapentadol Liconsa 50 mg prolonged-release tablets
Prolonged-release tablet

Compare
PA1239/029/002
Authorised: 05/08/2022
Laboratorios LICONSA, S.A.
SPC PIL
Tapimio 100 mg prolonged-release tablets
Prolonged-release tablet

Compare
PA23229/005/003
Authorised: 04/11/2022
Neuraxpharm Ireland Limited
SPC PIL
Tapimio 150 mg prolonged-release tablets
Prolonged-release tablet

Compare
PA23229/005/004
Authorised: 04/11/2022
Neuraxpharm Ireland Limited
SPC PIL
Tapimio 200 mg prolonged-release tablets
Prolonged-release tablet

Compare
PA23229/005/005
Authorised: 04/11/2022
Neuraxpharm Ireland Limited
SPC PIL
Tapimio 25 mg prolonged-release tablets
Prolonged-release tablet

Compare
PA23229/005/001
Authorised: 04/11/2022
Neuraxpharm Ireland Limited
SPC PIL
Tapimio 250 mg prolonged-release tablets
Prolonged-release tablet

Compare
PA23229/005/006
Authorised: 04/11/2022
Neuraxpharm Ireland Limited
SPC PIL
Tapimio 50 mg prolonged-release tablets
Prolonged-release tablet

Compare
PA23229/005/002
Authorised: 04/11/2022
Neuraxpharm Ireland Limited
SPC PIL
Taptiqom 15 micrograms/ml + 5 mg/ml eye drops, solution in single-dose container
Eye drops, solution in single-dose container

Compare
PPA0465/475/001
Authorised: 18/06/2021
PCO Manufacturing Ltd.
SPC PIL
Taptiqom 15 micrograms/ml + 5 mg/ml eye drops, solution in single-dose container
Eye drops, solution in single-dose container

Compare
PA0879/003/001
Authorised: 28/11/2014
Santen OY
SPC PIL